NCT03320083
- Conditions
- Behavior, Breast Feeding, Dyssomnias, +6 more
- Locations
-
Not specified
Clinical trial condition
Sleep Initiation and Maintenance Disorders
Explore clinical trials studying Sleep Initiation and Maintenance Disorders. Study availability and eligibility vary by location and protocol.
128 public trials
5 recruiting studies
Sleep Initiation and Maintenance Disorders trial results
Completed
Disturbed Sleep Model Study.
NCT00440323
- Conditions
- Dyssomnias, Mental Disorders, Nervous System Diseases, +3 more
- Locations
-
- GSK Investigational Site Guildford, Surrey, United Kingdom
Completed
Efficacy and Safety of Volinanserin on Sleep Maintenance Insomnia - Polysomnographic Study
NCT00464243
- Conditions
- Dyssomnias, Mental Disorders, Nervous System Diseases, +4 more
- Locations
-
- Sanofi-Aventis Administrative Office Bridgewater, New Jersey, United States
- Sanofi-Aventis Administrative Office Cove, New South Wales, Australia
- Sanofi-Aventis Administrative Office Vienna, Austria
- Sanofi-Aventis Administrative Office Laval, Quebec, Canada
NCT00650871
- Conditions
- Dyssomnias, Mental Disorders, Nervous System Diseases, +3 more
- Locations
-
- GSK Investigational Site San Diego, California, United States
- GSK Investigational Site Atlanta, Georgia, United States
- GSK Investigational Site New York, United States
- GSK Investigational Site Durham, North Carolina, United States
NCT00495729
- Conditions
- Dyssomnias, Mental Disorders, Nervous System Diseases, +3 more
- Locations
-
- GSK Investigational Site Berlin, Germany
NCT00495274
- Conditions
- Dyssomnias, Mental Disorders, Nervous System Diseases, +3 more
- Locations
-
- GSK Investigational Site Verona, Veneto, Italy
NCT00520663
- Conditions
- Dyssomnias, Mental Disorders, Nervous System Diseases, +4 more
- Locations
-
- GSK Investigational Site Tranent, West Lothian, United Kingdom
Completed
A Study With GW597599 And GR205171: Potential New Drugs For The Treatment Of Primary Insomnia
NCT00606697
- Conditions
- Dyssomnias, Mental Disorders, Nervous System Diseases, +3 more
- Locations
-
- GSK Investigational Site Mannheim, Baden-Wurttemberg, Germany
- GSK Investigational Site Munich, Bavaria, Germany
- GSK Investigational Site Schwerin, Mecklenburg-Vorpommern, Germany
- GSK Investigational Site Dortmund, North Rhine-Westphalia, Germany
NCT00383643
- Conditions
- Dyssomnias, Mental Disorders, Nervous System Diseases, +3 more
- Locations
-
- Stanford University School of Medicine Stanford, California, United States
NCT00230737
- Conditions
- Dyssomnias, Mental Disorders, Nervous System Diseases, +7 more
- Locations
-
- University of Pennsylvania Philadelphia, Pennsylvania, United States